Krystal Biotech, Inc. (KRYS)
305.23
-0.45
(-0.15%)
USD |
NASDAQ |
Nov 13, 16:00
306.00
+0.77
(+0.25%)
After-Hours: 07:49
Krystal Biotech Price : 305.23 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 305.68 | 306.72 | 300.39 | 305.23 | 110286.0 |
| Nov 12, 2026 | 307.72 | 309.68 | 304.06 | 305.68 | 157100.0 |
| Nov 11, 2026 | 308.09 | 311.05 | 303.59 | 308.81 | 174779.0 |
| Nov 10, 2026 | 302.60 | 307.48 | 300.86 | 306.50 | 196378.0 |
| Nov 09, 2026 | 302.65 | 310.66 | 297.52 | 303.06 | 281830.0 |
| Nov 06, 2026 | 298.31 | 305.60 | 297.52 | 300.88 | 234214.0 |
| Nov 05, 2026 | 310.22 | 314.24 | 299.63 | 300.25 | 400941.0 |
| Nov 04, 2026 | 314.75 | 314.75 | 301.80 | 310.84 | 414444.0 |
| Nov 03, 2026 | 293.49 | 305.43 | 293.01 | 305.03 | 603125.0 |
| Nov 02, 2026 | 314.21 | 317.00 | 281.40 | 295.90 | 1.204M |
| Oct 30, 2026 | 326.37 | 332.63 | 319.95 | 332.29 | 330314.0 |
| Oct 29, 2026 | 323.77 | 326.98 | 319.43 | 324.55 | 190769.0 |
| Oct 28, 2026 | 317.81 | 322.08 | 315.86 | 321.42 | 199842.0 |
| Oct 27, 2026 | 311.52 | 321.02 | 311.52 | 320.58 | 212809.0 |
| Oct 26, 2026 | 313.56 | 317.76 | 309.63 | 313.66 | 223645.0 |
| Oct 23, 2026 | 318.91 | 318.91 | 310.56 | 311.50 | 270066.0 |
| Oct 22, 2026 | 320.44 | 328.48 | 317.05 | 320.13 | 245207.0 |
| Oct 21, 2026 | 324.31 | 327.35 | 319.83 | 322.17 | 468869.0 |
| Oct 20, 2026 | 321.80 | 328.76 | 321.26 | 325.42 | 195450.0 |
| Oct 19, 2026 | 320.30 | 321.65 | 314.22 | 320.25 | 207698.0 |
| Oct 16, 2026 | 329.94 | 331.02 | 315.38 | 316.58 | 226233.0 |
| Oct 15, 2026 | 332.98 | 338.91 | 328.51 | 330.00 | 288017.0 |
| Oct 14, 2026 | 320.41 | 330.96 | 319.01 | 330.69 | 277537.0 |
| Oct 13, 2026 | 331.48 | 331.93 | 320.95 | 321.16 | 281312.0 |
| Oct 12, 2026 | 329.14 | 334.27 | 328.53 | 332.07 | 168068.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 165.04 |
| Ionis Pharmaceuticals, Inc. | 29.06 |
| Ultragenyx Pharmaceutical, Inc. | 16.08 |
| BridgeBio Pharma, Inc. | 78.30 |
| Cytokinetics, Inc. | 56.13 |
Price Related Metrics
| PE Ratio | 41.45 |
| PS Ratio | 19.85 |
| PEG Ratio | 3.964 |
| Price to Book Value | 6.300 |
| Price to Free Cash Flow | 30.08 |
| Earnings Yield | 2.41% |
| Market Cap | 9.044B |
| PEGY Ratio | 3.964 |
| Operating PE Ratio | 41.00 |
| Normalized PE Ratio | 41.45 |